SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH LISTED COMPANY


Any AUS or NZ company

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

RACE ONCOLOGY LTD(RAC)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of RAC: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group Level 5, 126 Phillip Street Sydney NSW 2000

Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
Fax :
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000RAC3
Address: Level 36, Gateway 1 Macquarie Place SYDNEY NSW 2000
Tel:  + 61 2 8051 3043 Fax: 

Date first listed: 13/07/2016
Company Secretary: Peter Webse
Sector: Pharmaceuticals & Biotechnology Industry Group: 
Activities: Historically Mining On 11 April 2016 the company entered into a Heads of Agreement to acquire the Intellectual Property Of Update Pharma, Inc. (a company incorporated in the State of Nevada) pertaining to the oncology drug, Bisantrene

News & Events

Expand this box to read and print

listed entity carried for record purposes only

13/07/2016

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    10/01/2022John Cullity-300,000$3.317$995,174
    14/12/2021Daniel Tillett2,271$3.405$7,732
    10/12/2021Daniel Tillett17,729$3.339$59,189
    04/11/2021John Cullity-217,878$3.259$709,999
    02/09/2021John Cullity-61,745$3.123$192,799

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    John CullityNon Exec Chairman06/04/2018
    Phillip LynchManaging Director, CEO01/06/2020
    Mary HarneyNon Exec Director08/02/2021
    Daniel TillettExecutive Director17/09/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Borje AnderssonExecutive Director01/02/202010/12/2020
    William GarnerNon Exec Director13/07/201628/10/2020
    Chris NtoumenopoulosNon Exec Director13/07/201628/10/2020
    Peter MolloyManaging Director, CEO13/07/201620/05/2020
    Brendan de KauweNon Exec Director13/07/201606/04/2018

    Date of first appointment, title may have changed.